Transdermal

Got Pain?

Got Pain?

Transdermal Pharmaceuticals Clinically Proven APPA | September 2016 Chain Drug Review | July 2016 Chain Drugstore Daily | April 2016              
Transdermal Gel Offers New Option for Gout

Transdermal Gel Offers New Option for Gout

By Alesia Wagner, Chain Drug Review
Gout, an extremely painful form of inflammatory arthritis, affects more than 4% of Americans and about 10% of men over the age of 60. It is more common in women after menopause. The disease occurs due to an excess of the bodily waste uric acid. The acid is deposited as needle-like crystals in the joints or in soft tissue. These crystals cause redness, swelling, stiffness and intense pain in the joints, which in turn can create gout flares.

ColciGel is a new prescription medication for the treatment of acute flares of gout. It is a transdermal gel that contains homeopathic colchicine (colchicinum 4X) that is applied directly to the sites of a flare. ColciGel penetrates the dermal layer, resulting in the reduction of inflammation and pain associated with the flare.

Incremental Approach to Pain Relief Advocated

Incremental Approach to Pain Relief Advocated

May 18th, 2015 – As Seen In Chain Drug Review, Rx News: Chronic pain affects more than 100 million adults to the point where they are unable to work, manage their daily tasks and even participate in their relationships at home, says Robert Wilbur, director of...
Studies Support Efficacy of Gensco Transdermal Analgesics

Studies Support Efficacy of Gensco Transdermal Analgesics

Chain Drug Review | August 5, 2013 INVERNESS, Fla. — A two-year-old company based here says two recent studies show that its transdermal drugs can significantly reduce pain. Executives at Gensco Laboratories say the studies show that the company’s...